Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#545 most reported symptom for this vaccine
Antinuclear antibody has been reported 50 times in association with Zoster Live (Zostavax) vaccination in VAERS. This represents 0.0% of all 140,312 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 9 involved hospitalization (18.0%).
Antinuclear antibody is the #545 most frequently reported symptom for Zoster Live (Zostavax) out of 2827 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 50 reports of Antinuclear antibody after Zoster Live (Zostavax) vaccination may seem alarming, but context is critical. With 140,312 total reports for this vaccine (representing many millions of doses), Antinuclear antibody appears in only 0.0% of reports.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.